CRP and Huntington disease: Cross-sectional at baseline, longitudinal with 8-week follow-up, double-blinded, placebo-controlled trial, 37 HD patients (mean: age 52, HD vintage 54 months, HD dose unknown, cellulose acetate membranes); 20 treated every day with cocktail containing 250 mg of AA. Concentrations of f-2 isoprostane, protein carbonyls, CRP and IL-6 in pre-HD plasma was measured.